Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.
Learn moreOver the past several years, we've seen that while the importance of in-person engagement remains significant, the value of digital and virtual engagement has grown considerably. HCPs increasingly expect a variety of engagement channel options, and also want the ability to directly influence when, where, and how they are engaged by pharma companies. As a result, most pharma organizations have identified innovative customer engagement models and omnichannel strategies as a top priority.
During the pandemic, we also saw most biopharma organizations invest significantly in their virtual and digital marketing channels and technologies, in many instances trying to scale them almost overnight. However, few (if any) biopharma organizations can declare definitive success when it comes to effective customer engagement, and the industry as a whole is recognized as something of a laggard.
In this IQVIA-hosted panel discussion, industry experts explore what must be collectively achieved in order to move the needle and deliver more compelling and differentiating customer experiences going forward.
MATTHEW SMITH, Senior Principal, New Commercial Models & Digital Health, Strategy Consulting, IQVIA